Search by Drug Name or NDC
NDC 69097-0248-03 Darunavir 600 and 800 mg 600 mg/1 Details
Darunavir 600 and 800 mg 600 mg/1
Darunavir 600 and 800 mg is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is DARUNAVIR HYDRATE.
Product Information
| NDC | 69097-0248 |
|---|---|
| Product ID | 69097-248_bdbfc235-3cca-4fa0-be70-9c34cfb91feb |
| Associated GPIs | |
| GCN Sequence Number | 063719 |
| GCN Sequence Number Description | darunavir TABLET 600 MG ORAL |
| HIC3 | W5P |
| HIC3 Description | ANTIVIRALS, HIV-SPEC, NON-PEPTIDIC PROTEASE INHIB |
| GCN | 99434 |
| HICL Sequence Number | 033842 |
| HICL Sequence Number Description | DARUNAVIR |
| Brand/Generic | Generic |
| Proprietary Name | Darunavir 600 and 800 mg |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | darunavir |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 600 |
| Active Ingredient Units | mg/1 |
| Substance Name | DARUNAVIR HYDRATE |
| Labeler Name | Cipla USA Inc. |
| Pharmaceutical Class | Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206288 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69097-0248-03 (69097024803)
| NDC Package Code | 69097-248-03 |
|---|---|
| Billing NDC | 69097024803 |
| Package | 60 TABLET in 1 BOTTLE (69097-248-03) |
| Marketing Start Date | 2023-11-29 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 3.74957 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | DARUNAVIR 600 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis